RC3H1 and neoplasm: Also, in engineered T cells targeting tumour antigens, knocking out both Roquin-1 and Regnase-1 led to a significant increase in T cell accumulation within tumours and reduced expression of exhaustion markers, resulting in improved tumour clearance [26].